{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:07:15Z","timestamp":1792670835932,"version":"4.5.0"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["813409"],"award-info":[{"award-number":["813409"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["813409"],"award-info":[{"award-number":["813409"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["813409"],"award-info":[{"award-number":["813409"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02066-6","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T12:03:30Z","timestamp":1738325010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Protease-activated receptors in vascular smooth muscle cells: a bridge between thrombo-inflammation and vascular remodelling"],"prefix":"10.1186","volume":"23","author":[{"given":"Anxhela","family":"Habibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Schurgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"issue":"4","key":"2066_CR1","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1172\/JCI116031","volume":"90","author":"NA Nelken","year":"1992","unstructured":"Nelken NA, Soifer SJ, O\u2019Keefe J, Vu TK, Charo IF, Coughlin SR. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest. 1992;90(4):1614\u201321.","journal-title":"J Clin Invest"},{"issue":"5","key":"2066_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/jcp.2003.015156","volume":"57","author":"C Napoli","year":"2004","unstructured":"Napoli C, de Nigris F, Wallace JL, Hollenberg MD, Tajana G, De Rosa G, et al. Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions. J Clin Pathol. 2004;57(5):513\u20136.","journal-title":"J Clin Pathol"},{"issue":"8","key":"2066_CR3","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1161\/ATVBAHA.120.314560","volume":"40","author":"SJ Shin","year":"2020","unstructured":"Shin SJ, Hang HT, Thang BQ, Shimoda T, Sakamoto H, Osaka M, et al. Role of PAR1-Egr1 in the initiation of thoracic aortic aneurysm in Fbln4-Deficient mice. Arterioscler Thromb Vasc Biol. 2020;40(8):1905\u201317.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2066_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1476-5381.2010.00705.x","volume":"160","author":"UJK Soh","year":"2010","unstructured":"Soh UJK, Dores MR, Chen B, Trejo J. Signal transduction by protease-activated receptors. Br J Pharmacol. 2010;160(2):191\u2013203.","journal-title":"Br J Pharmacol"},{"key":"2066_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12959-019-0194-8","volume":"17","author":"DM Heuberger","year":"2019","unstructured":"Heuberger DM, Schuepbach RA. Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases. Thromb J. 2019;17:4.","journal-title":"Thromb J"},{"issue":"6","key":"2066_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","volume":"64","author":"TK Vu","year":"1991","unstructured":"Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64(6):1057\u201368.","journal-title":"Cell"},{"issue":"20","key":"2066_CR7","doi-asserted-by":"publisher","first-page":"9208","DOI":"10.1073\/pnas.91.20.9208","volume":"91","author":"S Nystedt","year":"1994","unstructured":"Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci. 1994;91(20):9208\u201312.","journal-title":"Proc Natl Acad Sci"},{"issue":"6624","key":"2066_CR8","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/386502a0","volume":"386","author":"H Ishihara","year":"1997","unstructured":"Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 1997;386(6624):502\u20136.","journal-title":"Nature"},{"issue":"6694","key":"2066_CR9","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/29325","volume":"394","author":"ML Kahn","year":"1998","unstructured":"Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, et al. A dual thrombin receptor system for platelet activation. Nature. 1998;394(6694):690\u20134.","journal-title":"Nature"},{"key":"2066_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.thromres.2019.02.032","volume":"177","author":"DM Heuberger","year":"2019","unstructured":"Heuberger DM, Franchini AG, Madon J, Schuepbach RA. Thrombin cleaves and activates the protease-activated receptor 2 dependent on thrombomodulin co-receptor availability. Thromb Res. 2019;177:91\u2013101.","journal-title":"Thromb Res"},{"issue":"2","key":"2066_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1161\/01.RES.0000255685.06922.c7","volume":"100","author":"E Bretschneider","year":"2007","unstructured":"Bretschneider E, Uzonyi B, Weber AA, Fischer JW, Pape R, L\u00f6tzer K, et al. Human vascular smooth muscle cells express functionally active endothelial cell protein C receptor. Circ Res. 2007;100(2):255\u201362.","journal-title":"Circ Res"},{"issue":"1","key":"2066_CR12","doi-asserted-by":"publisher","first-page":"17172","DOI":"10.1038\/s41598-017-17508-6","volume":"7","author":"F Sanada","year":"2017","unstructured":"Sanada F, Muratsu J, Otsu R, Shimizu H, Koibuchi N, Uchida K, et al. Local production of activated factor X in atherosclerotic Plaque Induced Vascular smooth muscle cell senescence. Sci Rep. 2017;7(1):17172.","journal-title":"Sci Rep"},{"issue":"3","key":"2066_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/cvr\/cvt112","volume":"99","author":"A B\u00f6hm","year":"2013","unstructured":"B\u00f6hm A, Fl\u00f6\u00dfer A, Ermler S, Fender AC, L\u00fcth A, Kleuser B, et al. Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells. Cardiovasc Res. 2013;99(3):505\u201313.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"2066_CR14","doi-asserted-by":"publisher","first-page":"5756","DOI":"10.1074\/jbc.M110.201228","volume":"286","author":"J Disse","year":"2011","unstructured":"Disse J, Petersen HH, Larsen KS, Persson E, Esmon N, Esmon CT, et al. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors. J Biol Chem. 2011;286(7):5756\u201367.","journal-title":"J Biol Chem"},{"issue":"5","key":"2066_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0049-3848(02)00345-6","volume":"107","author":"K Marutsuka","year":"2002","unstructured":"Marutsuka K, Hatakeyama K, Sato Y, Yamashita A, Sumiyoshi A, Asada Y. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor\/factor VIIa complex. Thromb Res. 2002;107(5):271\u20136.","journal-title":"Thromb Res"},{"issue":"6","key":"2066_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1182\/blood-2017-02-768218","volume":"131","author":"AS Rothmeier","year":"2018","unstructured":"Rothmeier AS, Liu E, Chakrabarty S, Disse J, Mueller BM, \u00d8stergaard H, et al. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling. Blood. 2018;131(6):674\u201385.","journal-title":"Blood"},{"issue":"8","key":"2066_CR17","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1111\/febs.15829","volume":"288","author":"A Chandrabalan","year":"2021","unstructured":"Chandrabalan A, Ramachandran R. Molecular mechanisms regulating proteinase-activated receptors (PARs). Febs j. 2021;288(8):2697\u2013726.","journal-title":"Febs j"},{"issue":"32","key":"2066_CR18","doi-asserted-by":"publisher","first-page":"23105","DOI":"10.1074\/jbc.M113.467019","volume":"288","author":"KM Austin","year":"2013","unstructured":"Austin KM, Nguyen N, Javid G, Covic L, Kuliopulos A. Noncanonical matrix metalloprotease-1-protease-activated receptor-1 signaling triggers vascular smooth muscle cell dedifferentiation and arterial stenosis. J Biol Chem. 2013;288(32):23105\u201315.","journal-title":"J Biol Chem"},{"issue":"1","key":"2066_CR19","doi-asserted-by":"publisher","first-page":"e15956","DOI":"10.1371\/journal.pone.0015956","volume":"6","author":"Z-D Shi","year":"2011","unstructured":"Shi Z-D, Wang H, Tarbell JM. Heparan Sulfate proteoglycans mediate interstitial Flow Mechanotransduction regulating MMP-13 expression and cell motility via FAK-ERK in 3D collagen. PLoS ONE. 2011;6(1):e15956.","journal-title":"PLoS ONE"},{"issue":"1","key":"2066_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/01.ATV.0000100402.69997.C3","volume":"24","author":"C Johnson","year":"2004","unstructured":"Johnson C, Galis ZS. Matrix metalloproteinase-2 and\u2013\u20099 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler Thromb Vasc Biol. 2004;24(1):54\u201360.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"18","key":"2066_CR21","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMra1011670","volume":"364","author":"JI Borissoff","year":"2011","unstructured":"Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med. 2011;364(18):1746\u201360.","journal-title":"N Engl J Med"},{"issue":"6778","key":"2066_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/35007085","volume":"404","author":"M Nakanishi-Matsui","year":"2000","unstructured":"Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR. PAR3 is a cofactor for PAR4 activation by thrombin. Nature. 2000;404(6778):609\u201313.","journal-title":"Nature"},{"issue":"8","key":"2066_CR23","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/j.1538-7836.2005.01377.x","volume":"3","author":"COUGHLIN SR","year":"2005","unstructured":"COUGHLIN SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost. 2005;3(8):1800\u201314.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2066_CR24","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1172\/JCI6042","volume":"103","author":"ML Kahn","year":"1999","unstructured":"Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999;103(6):879\u201387.","journal-title":"J Clin Invest"},{"issue":"2","key":"2066_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1055\/s-2007-999001","volume":"22","author":"CA McNamara","year":"1996","unstructured":"McNamara CA, Sarembock IJ, Bachhuber BG, Stouffer GA, Ragosta M, Barry W, et al. Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis. Semin Thromb Hemost. 1996;22(2):139\u201344.","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"2066_CR26","first-page":"876","volume":"112","author":"AR Rezaie","year":"2014","unstructured":"Rezaie AR. Protease-activated receptor signalling by coagulation proteases in endothelial cells. Thromb Haemost. 2014;112(5):876\u201382.","journal-title":"Thromb Haemost"},{"issue":"25","key":"2066_CR27","doi-asserted-by":"publisher","first-page":"14910","DOI":"10.1074\/jbc.271.25.14910","volume":"271","author":"S Nystedt","year":"1996","unstructured":"Nystedt S, Ramakrishnan V, Sundelin J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem. 1996;271(25):14910\u20135.","journal-title":"J Biol Chem"},{"issue":"1","key":"2066_CR28","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1152\/physrev.00044.2021","volume":"103","author":"CJ Peach","year":"2023","unstructured":"Peach CJ, Edgington-Mitchell LE, Bunnett NW, Schmidt BL. Protease-activated receptors in health and disease. Physiol Rev. 2023;103(1):717\u201385.","journal-title":"Physiol Rev"},{"issue":"8","key":"2066_CR29","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1111\/j.1538-7836.2012.04825.x","volume":"10","author":"RA Schuepbach","year":"2012","unstructured":"Schuepbach RA, Madon J, Ender M, Galli P, Riewald M. Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects. J Thromb Haemost. 2012;10(8):1675\u201384.","journal-title":"J Thromb Haemost"},{"key":"2066_CR30","doi-asserted-by":"crossref","unstructured":"Zhao P, Metcalf M, Bunnett NW. Biased signaling of protease-activated receptors. Front Endocrinol. 2014;5.","DOI":"10.3389\/fendo.2014.00067"},{"issue":"5535","key":"2066_CR31","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1126\/science.1061259","volume":"293","author":"CT Griffin","year":"2001","unstructured":"Griffin CT, Srinivasan Y, Zheng Y-W, Huang W, Coughlin SR. A role for thrombin receptor signaling in endothelial cells during Embryonic Development. Science. 2001;293(5535):1666\u201370.","journal-title":"Science"},{"issue":"6582","key":"2066_CR32","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/381516a0","volume":"381","author":"AJ Connolly","year":"1996","unstructured":"Connolly AJ, Ishihara H, Kahn ML, Farese RV, Coughlin SR. Role of the thrombin receptor in development and evidence for a second receptor. Nature. 1996;381(6582):516\u20139.","journal-title":"Nature"},{"issue":"22","key":"2066_CR33","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.1182\/bloodadvances.2020003299","volume":"4","author":"M Saffarzadeh","year":"2020","unstructured":"Saffarzadeh M, Grunz K, Nguyen TS, Lee YK, Kitano M, Danckwardt S, et al. Macrophage protease-activated receptor 2 regulates fetal liver erythropoiesis in mice. Blood Adv. 2020;4(22):5810\u201324.","journal-title":"Blood Adv"},{"issue":"12","key":"2066_CR34","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1161\/01.ATV.19.12.3014","volume":"19","author":"W-m Cheung","year":"1999","unstructured":"Cheung W-m, D\u2019Andrea MR, Andrade-Gordon P, Damiano BP. Altered vascular Injury responses in mice deficient in protease-activated Receptor-1. Arterioscler Thromb Vasc Biol. 1999;19(12):3014\u201324.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"2066_CR35","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1182\/blood-2003-04-1130","volume":"102","author":"H Kataoka","year":"2003","unstructured":"Kataoka H, Hamilton JR, McKemy DD, Camerer E, Zheng Y-W, Cheng A, et al. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood. 2003;102(9):3224\u201331.","journal-title":"Blood"},{"key":"2066_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1472-6793-8-20","volume":"8","author":"JJ McGuire","year":"2008","unstructured":"McGuire JJ, Van Vliet BN, Halfyard SJ. Blood pressures, heart rate and locomotor activity during salt loading and angiotensin II infusion in protease-activated receptor 2 (PAR2) knockout mice. BMC Physiol. 2008;8:20.","journal-title":"BMC Physiol"},{"issue":"6","key":"2066_CR37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1161\/ATVBAHA.117.310082","volume":"38","author":"SM Jones","year":"2018","unstructured":"Jones SM, Mann A, Conrad K, Saum K, Hall DE, McKinney LM, et al. PAR2 (protease-Activated receptor 2) Deficiency attenuates atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2018;38(6):1271\u201382.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2066_CR38","doi-asserted-by":"crossref","unstructured":"Zuo P, Zuo Z, Zheng Y, Wang X, Zhou Q, Chen L et al. Protease-activated Receptor-2 Deficiency attenuates atherosclerotic lesion progression and instability in apolipoprotein E-Deficient mice. Front Pharmacol. 2017;8.","DOI":"10.3389\/fphar.2017.00647"},{"issue":"16","key":"2066_CR39","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.118.033544","volume":"138","author":"T Hara","year":"2018","unstructured":"Hara T, Phuong PT, Fukuda D, Yamaguchi K, Murata C, Nishimoto S, et al. Protease-activated Receptor-2 plays a critical role in vascular inflammation and atherosclerosis in apolipoprotein E-Deficient mice. Circulation. 2018;138(16):1706\u201319.","journal-title":"Circulation"},{"issue":"6851","key":"2066_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/35092573","volume":"413","author":"GR Sambrano","year":"2001","unstructured":"Sambrano GR, Weiss EJ, Zheng Y-W, Huang W, Coughlin SR. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature. 2001;413(6851):74\u20138.","journal-title":"Nature"},{"issue":"5","key":"2066_CR41","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/jcbfm.2009.283","volume":"30","author":"Y Mao","year":"2010","unstructured":"Mao Y, Zhang M, Tuma RF, Kunapuli SP. Deficiency of PAR4 attenuates cerebral ischemia\/reperfusion injury in mice. J Cereb Blood Flow Metab. 2010;30(5):1044\u201352.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"2066_CR42","doi-asserted-by":"publisher","first-page":"cp13","DOI":"10.1126\/sageke.2001.1.cp13","volume":"2001","author":"GC Williams","year":"2001","unstructured":"Williams GC, Pleiotropy. Natural selection, and the evolution of Senescence. Sci Aging Knowl Environ. 2001;2001(1):cp13\u2013cp.","journal-title":"Sci Aging Knowl Environ"},{"issue":"14","key":"2066_CR43","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1113\/JP270033","volume":"593","author":"G Wang","year":"2015","unstructured":"Wang G, Jacquet L, Karamariti E, Xu Q. Origin and differentiation of vascular smooth muscle cells. J Physiol. 2015;593(14):3013\u201330.","journal-title":"J Physiol"},{"key":"2066_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4615-5543-8_14","volume-title":"Muscle physiology and Biochemistry","author":"K Sobue","year":"1999","unstructured":"Sobue K, Hayashi Ki, Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. In: Imai S, Ohtsuki I, Endo M, editors. Muscle physiology and Biochemistry. Boston, MA: Springer US; 1999. pp. 105\u201318."},{"key":"2066_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jvssci.2021.04.001","volume":"2","author":"R Chakraborty","year":"2021","unstructured":"Chakraborty R, Chatterjee P, Dave JM, Ostriker AC, Greif DM, Rzucidlo EM, et al. Targeting smooth muscle cell phenotypic switching in vascular disease. JVS-Vascular Sci. 2021;2:79\u201394.","journal-title":"JVS-Vascular Sci"},{"issue":"3","key":"2066_CR46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1152\/physrev.1995.75.3.487","volume":"75","author":"GK Owens","year":"1995","unstructured":"Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75(3):487\u2013517.","journal-title":"Physiol Rev"},{"issue":"1","key":"2066_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00018-021-04079-z","volume":"79","author":"F Zhang","year":"2021","unstructured":"Zhang F, Guo X, Xia Y, Mao L. An update on the phenotypic switching of vascular smooth muscle cells in the pathogenesis of atherosclerosis. Cell Mol Life Sci. 2021;79(1):6.","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"2066_CR48","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/CIRCRESAHA.115.304634","volume":"115","author":"S Feil","year":"2014","unstructured":"Feil S, Fehrenbacher B, Lukowski R, Essmann F, Schulze-Osthoff K, Schaller M, et al. Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ Res. 2014;115(7):662\u20137.","journal-title":"Circ Res"},{"issue":"8","key":"2066_CR49","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-019-0512-5","volume":"25","author":"RC Wirka","year":"2019","unstructured":"Wirka RC, Wagh D, Paik DT, Pjanic M, Nguyen T, Miller CL, et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat Med. 2019;25(8):1280\u20139.","journal-title":"Nat Med"},{"issue":"5","key":"2066_CR50","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1074\/jbc.M410075200","volume":"280","author":"JD Davies","year":"2005","unstructured":"Davies JD, Carpenter KL, Challis IR, Figg NL, McNair R, Proudfoot D, et al. Adipocytic differentiation and liver x receptor pathways regulate the accumulation of triacylglycerols in human vascular smooth muscle cells. J Biol Chem. 2005;280(5):3911\u20139.","journal-title":"J Biol Chem"},{"issue":"6","key":"2066_CR51","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","volume":"109","author":"CM Shanahan","year":"2011","unstructured":"Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109(6):697\u2013711.","journal-title":"Circ Res"},{"issue":"10","key":"2066_CR52","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/01.RES.0000147961.09840.fb","volume":"95","author":"BR Wamhoff","year":"2004","unstructured":"Wamhoff BR, Hoofnagle MH, Burns A, Sinha S, McDonald OG, Owens GK. A G\/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ Res. 2004;95(10):981\u20138.","journal-title":"Circ Res"},{"key":"2066_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2045-824X-6-21","volume":"6","author":"BP Herring","year":"2014","unstructured":"Herring BP, Hoggatt AM, Burlak C, Offermanns S. Previously differentiated medial vascular smooth muscle cells contribute to neointima formation following vascular injury. Vasc Cell. 2014;6:21.","journal-title":"Vasc Cell"},{"issue":"3","key":"2066_CR54","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.bbrc.2006.05.196","volume":"346","author":"H Wang","year":"2006","unstructured":"Wang H, Yan S, Chai H, Riha GM, Li M, Yao Q, et al. Shear stress induces endothelial transdifferentiation from mouse smooth muscle cells. Biochem Biophys Res Commun. 2006;346(3):860\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"2066_CR55","doi-asserted-by":"crossref","unstructured":"Jaminon A, Reesink K, Kroon A, Schurgers L. The role of vascular smooth muscle cells in arterial remodeling: focus on calcification-related processes. Int J Mol Sci. 2019;20(22).","DOI":"10.3390\/ijms20225694"},{"issue":"1","key":"2066_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1146\/annurev-physiol-012110-142315","volume":"74","author":"MR Alexander","year":"2012","unstructured":"Alexander MR, Owens GK. Epigenetic Control of Smooth Muscle Cell Differentiation and phenotypic switching in Vascular Development and Disease. Annu Rev Physiol. 2012;74(1):13\u201340.","journal-title":"Annu Rev Physiol"},{"issue":"19","key":"2066_CR57","doi-asserted-by":"publisher","first-page":"10585","DOI":"10.3390\/ijms221910585","volume":"22","author":"JV Ashraf","year":"2021","unstructured":"Ashraf JV, Al Haj Zen A. Role of vascular smooth muscle cell phenotype switching in Arteriogenesis. Int J Mol Sci. 2021;22(19):10585.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2066_CR58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00418-015-1386-3","volume":"145","author":"M-J Zhang","year":"2016","unstructured":"Zhang M-J, Zhou Y, Chen L, Wang Y-Q, Wang X, Pi Y, et al. An overview of potential molecular mechanisms involved in VSMC phenotypic modulation. Histochem Cell Biol. 2016;145(2):119\u201330.","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"2066_CR59","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.vph.2014.06.001","volume":"62","author":"MA Alberelli","year":"2014","unstructured":"Alberelli MA, De Candia E. Functional role of protease activated receptors in vascular biology. Vascul Pharmacol. 2014;62(2):72\u201381.","journal-title":"Vascul Pharmacol"},{"issue":"8","key":"2066_CR60","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1161\/CIRCULATIONAHA.109.907121","volume":"122","author":"JI Borissoff","year":"2010","unstructured":"Borissoff JI, Heeneman S, Kilin\u00e7 E, Kass\u00e1k P, Van Oerle R, Winckers K, et al. Early atherosclerosis exhibits an enhanced procoagulant state. Circulation. 2010;122(8):821\u201330.","journal-title":"Circulation"},{"issue":"9","key":"2066_CR61","first-page":"2550","volume":"119","author":"CJ Scotton","year":"2009","unstructured":"Scotton CJ, Krupiczojc MA, K\u00f6nigshoff M, Mercer PF, Lee YC, Kaminski N, et al. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest. 2009;119(9):2550\u201363.","journal-title":"J Clin Invest"},{"issue":"1","key":"2066_CR62","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/01.ATV.0000043418.84185.3C","volume":"23","author":"JN Wilcox","year":"2003","unstructured":"Wilcox JN, Noguchi S, Casanova J. Extrahepatic synthesis of factor VII in human atherosclerotic vessels. Arterioscler Thromb Vasc Biol. 2003;23(1):136\u201341.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"2066_CR63","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.jacc.2017.01.057","volume":"69","author":"AH Hobbelt","year":"2017","unstructured":"Hobbelt AH, Spronk HM, Crijns H, Ten Cate H, Rienstra M, Van Gelder IC. Prethrombotic State in Young very low-risk patients with Atrial Fibrillation. J Am Coll Cardiol. 2017;69(15):1990\u20132.","journal-title":"J Am Coll Cardiol"},{"issue":"3 Suppl","key":"2066_CR64","doi-asserted-by":"publisher","first-page":"s26","DOI":"10.1378\/chest.124.3_suppl.26S","volume":"124","author":"CT Esmon","year":"2003","unstructured":"Esmon CT. The protein C pathway. Chest. 2003;124(3 Suppl):s26\u201332.","journal-title":"Chest"},{"issue":"20","key":"2066_CR65","doi-asserted-by":"publisher","first-page":"19808","DOI":"10.1074\/jbc.M500747200","volume":"280","author":"M Riewald","year":"2005","unstructured":"Riewald M, Ruf W. Protease-activated Receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from Thrombin Signaling*. J Biol Chem. 2005;280(20):19808\u201314.","journal-title":"J Biol Chem"},{"issue":"26","key":"2066_CR66","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1182\/blood-2012-08-452169","volume":"120","author":"LO Mosnier","year":"2012","unstructured":"Mosnier LO, Sinha RK, Burnier L, Bouwens EA, Griffin JH. Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. Blood. 2012;120(26):5237\u201346.","journal-title":"Blood"},{"issue":"19","key":"2066_CR67","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1182\/blood-2015-02-355974","volume":"125","author":"JH Griffin","year":"2015","unstructured":"Griffin JH, Zlokovic BV, Mosnier LO. Activated protein C: biased for translation. Blood. 2015;125(19):2898\u2013907.","journal-title":"Blood"},{"key":"2066_CR68","doi-asserted-by":"crossref","unstructured":"Bochenek ML, Gogiraju R, Gro\u00dfmann S, Krug J, Orth J, Reyda S et al. EPCR-PAR1 biased signaling regulates perfusion recovery and neovascularization in peripheral ischemia. JCI Insight. 2022;7(14).","DOI":"10.1172\/jci.insight.157701"},{"issue":"2","key":"2066_CR69","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1538-7836.2009.03682.x","volume":"8","author":"RA Schuepbach","year":"2010","unstructured":"Schuepbach RA, Riewald M. Coagulation factor Xa cleaves protease-activated receptor-1 and mediates signaling dependent on binding to the endothelial protein C receptor. J Thromb Haemost. 2010;8(2):379\u201388.","journal-title":"J Thromb Haemost"},{"issue":"21","key":"2066_CR70","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1182\/blood-2017-10-813527","volume":"131","author":"V Kondreddy","year":"2018","unstructured":"Kondreddy V, Wang J, Keshava S, Esmon CT, Rao LVM, Pendurthi UR. Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1. Blood. 2018;131(21):2379\u201392.","journal-title":"Blood"},{"issue":"2","key":"2066_CR71","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1161\/01.RES.0000255685.06922.c7","volume":"100","author":"E Bretschneider","year":"2007","unstructured":"Bretschneider E, Uzonyi B, Weber A-A, Fischer JW, Pape R, L\u00f6tzer K, et al. Human vascular smooth muscle cells Express functionally active endothelial cell protein C receptor. Circul Res. 2007;100(2):255\u201362.","journal-title":"Circul Res"},{"issue":"11","key":"2066_CR72","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1161\/ATVBAHA.111.235960","volume":"31","author":"MY Lee","year":"2011","unstructured":"Lee MY, Garvey SM, Ripley ML, Wamhoff BR. Genome-wide microarray analyses identify the protein C receptor as a novel calcineurin\/nuclear factor of activated T cells-dependent gene in vascular smooth muscle cell phenotypic modulation. Arterioscler Thromb Vasc Biol. 2011;31(11):2665\u201375.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7347","key":"2066_CR73","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317\u201325.","journal-title":"Nature"},{"issue":"2","key":"2066_CR74","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/01.HYP.25.2.155","volume":"25","author":"RW Alexander","year":"1995","unstructured":"Alexander RW. Hypertension and the pathogenesis of atherosclerosis. Hypertension. 1995;25(2):155\u201361.","journal-title":"Hypertension"},{"issue":"11","key":"2066_CR75","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1161\/01.CIR.96.11.3888","volume":"96","author":"VB Schini-Kerth","year":"1997","unstructured":"Schini-Kerth VB, Bassus S, Fisslthaler B, Kirchmaier CM, Busse R. Aggregating human platelets stimulate the expression of thrombin receptors in cultured vascular smooth muscle cells via the release of transforming growth factor-beta1 and platelet-derived growth factorAB. Circulation. 1997;96(11):3888\u201396.","journal-title":"Circulation"},{"issue":"3","key":"2066_CR76","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bbrc.2010.05.009","volume":"396","author":"S-W Chung","year":"2010","unstructured":"Chung S-W, Park J-W, Lee S-A, Eo S-K, Kim K. Thrombin promotes proinflammatory phenotype in human vascular smooth muscle cell. Biochem Biophys Res Commun. 2010;396(3):748\u201354.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2066_CR77","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/jth.15289","volume":"19","author":"RH van Gorp","year":"2021","unstructured":"van Gorp RH, Dijkgraaf I, Br\u00f6ker V, Bauwens M, Leenders P, Jennen D, et al. Off-target effects of oral anticoagulants - vascular effects of vitamin K antagonist and non-vitamin K antagonist oral anticoagulant dabigatran etexilate. J Thromb Haemost. 2021;19(5):1348\u201363.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2066_CR78","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1055\/s-0037-1615970","volume":"85","author":"RP Brandes","year":"2001","unstructured":"Brandes RP, Viedt C, Nguyen K, Beer S, Kreuzer J, Busse R, et al. Thrombin-induced MCP-1 expression involves activation of the p22phox-containing NADPH oxidase in human vascular smooth muscle cells. Thromb Haemost. 2001;85(6):1104\u201310.","journal-title":"Thromb Haemost"},{"key":"2066_CR79","doi-asserted-by":"publisher","first-page":"5799308","DOI":"10.1155\/2022\/5799308","volume":"2022","author":"X Zheng","year":"2022","unstructured":"Zheng X, Wang P, Jia M, Li Q, Zhang A, Zhou Q. Baicalin alleviates Thrombin-Induced inflammation in vascular smooth muscle cells. Biomed Res Int. 2022;2022:5799308.","journal-title":"Biomed Res Int"},{"issue":"44","key":"2066_CR80","doi-asserted-by":"publisher","first-page":"45935","DOI":"10.1074\/jbc.M406486200","volume":"279","author":"RK Ambasta","year":"2004","unstructured":"Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, Brandes RP. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem. 2004;279(44):45935\u201341.","journal-title":"J Biol Chem"},{"issue":"4","key":"2066_CR81","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.109.908319","volume":"121","author":"XL Niu","year":"2010","unstructured":"Niu XL, Madamanchi NR, Vendrov AE, Tchivilev I, Rojas M, Madamanchi C, et al. Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation. 2010;121(4):549\u201359.","journal-title":"Circulation"},{"issue":"11","key":"2066_CR82","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0891-5849(02)00789-X","volume":"32","author":"RP Brandes","year":"2002","unstructured":"Brandes RP, Miller FJ, Beer S, Haendeler J, Hoffmann J, Ha T, et al. The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. Free Radic Biol Med. 2002;32(11):1116\u201322.","journal-title":"Free Radic Biol Med"},{"issue":"17","key":"2066_CR83","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1161\/01.CIR.0000014611.28864.1E","volume":"105","author":"O Herkert","year":"2002","unstructured":"Herkert O, Diebold I, Brandes RP, Hess J, Busse R, G\u00f6rlach A. NADPH oxidase mediates tissue factor\u2013dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells. Circulation. 2002;105(17):2030\u20136.","journal-title":"Circulation"},{"issue":"2","key":"2066_CR84","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.atherosclerosis.2010.07.017","volume":"212","author":"G Demetz","year":"2010","unstructured":"Demetz G, Seitz I, Stein A, Steppich B, Groha P, Brandl R, et al. Tissue factor-factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells. Atherosclerosis. 2010;212(2):466\u201371.","journal-title":"Atherosclerosis"},{"key":"2066_CR85","doi-asserted-by":"crossref","unstructured":"Zhu Y, Qu J, He L, Zhang F, Zhou Z, Yang S et al. Calcium in vascular smooth muscle cell elasticity and adhesion: Novel insights into the mechanism of action. Front Physiol. 2019;10.","DOI":"10.3389\/fphys.2019.00852"},{"issue":"5","key":"2066_CR86","doi-asserted-by":"publisher","first-page":"H1924","DOI":"10.1152\/ajpheart.00921.2001","volume":"282","author":"M Rezaee","year":"2002","unstructured":"Rezaee M, Penta K, Quertermous T. Del1 mediates VSMC adhesion, migration, and proliferation through interaction with integrin \u03b1v\u03b23. Am J Physiol Heart Circ Physiol. 2002;282(5):H1924\u201332.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"2066_CR87","doi-asserted-by":"publisher","first-page":"e0119533","DOI":"10.1371\/journal.pone.0119533","volume":"10","author":"Z Hong","year":"2015","unstructured":"Hong Z, Reeves KJ, Sun Z, Li Z, Brown NJ, Meininger GA. Vascular smooth muscle cell stiffness and adhesion to collagen I modified by vasoactive agonists. PLoS ONE. 2015;10(3):e0119533.","journal-title":"PLoS ONE"},{"issue":"2","key":"2066_CR88","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0008-6363(98)00286-7","volume":"41","author":"AC Newby","year":"1999","unstructured":"Newby AC, Zaltsman AB. Fibrous cap formation or destruction \u2014 the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Res. 1999;41(2):345\u201360.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"2066_CR89","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1074\/jbc.M409739200","volume":"280","author":"N Dronadula","year":"2005","unstructured":"Dronadula N, Liu Z, Wang C, Cao H, Rao GN. STAT-3-dependent cytosolic phospholipase A2 expression is required for thrombin-induced vascular smooth muscle cell motility. J Biol Chem. 2005;280(4):3112\u201320.","journal-title":"J Biol Chem"},{"issue":"1","key":"2066_CR90","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.yjmcc.2003.09.014","volume":"36","author":"Z Wang","year":"2004","unstructured":"Wang Z, Castresana MR, Newman WH. Reactive oxygen species-sensitive p38 MAPK controls thrombin-induced migration of vascular smooth muscle cells. J Mol Cell Cardiol. 2004;36(1):49\u201356.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"2066_CR91","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/cvr\/cvr308","volume":"93","author":"DK Jagadeesha","year":"2012","unstructured":"Jagadeesha DK, Takapoo M, Banfi B, Bhalla RC, Miller FJ. Jr. Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration. Cardiovasc Res. 2012;93(3):406\u201313.","journal-title":"Cardiovasc Res"},{"key":"2066_CR92","doi-asserted-by":"publisher","first-page":"686200","DOI":"10.3389\/fcvm.2021.686200","volume":"8","author":"L Tian","year":"2021","unstructured":"Tian L, Huang CK, Ding F, Zhang R. Galectin-3 mediates Thrombin-Induced Vascular smooth muscle cell Migration. Front Cardiovasc Med. 2021;8:686200.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"2066_CR93","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","volume":"11","author":"RA de Boer","year":"2009","unstructured":"de Boer RA, Voors AA, Muntendam P, van Gilst WH, van Veldhuisen DJ. Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail. 2009;11(9):811\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"2066_CR94","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/jop.2010.0072","volume":"26","author":"S Narayan","year":"2010","unstructured":"Narayan S, Prasanna G, Tchedre K, Krishnamoorthy R, Yorio T. Thrombin-induced endothelin-1 synthesis and secretion in retinal pigment epithelial cells is rho kinase dependent. J Ocul Pharmacol Ther. 2010;26(5):389\u201397.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"2066_CR95","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1136\/annrheumdis-2016-210792","volume":"76","author":"E Planas-Rigol","year":"2017","unstructured":"Planas-Rigol E, Terrades-Garcia N, Corbera-Bellalta M, Lozano E, Alba MA, Segarra M, et al. Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis. Ann Rheum Dis. 2017;76(9):1624\u201334.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2066_CR96","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1161\/ATVBAHA.107.155754","volume":"28","author":"A Siegbahn","year":"2008","unstructured":"Siegbahn A, Johnell M, Nordin A, Aberg M, Velling T. TF\/FVIIa transactivate PDGFRbeta to regulate PDGF-BB-induced chemotaxis in different cell types: involvement of src and PLC. Arterioscler Thromb Vasc Biol. 2008;28(1):135\u201341.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2066_CR97","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/jth.12156","volume":"11","author":"M \u00c5berg","year":"2013","unstructured":"\u00c5berg M, Siegbahn A. Tissue factor non-coagulant signaling \u2013 molecular mechanisms and biological consequences with a focus on cell migration and apoptosis. J Thromb Haemost. 2013;11(5):817\u201325.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2066_CR98","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","volume":"118","author":"MR Bennett","year":"2016","unstructured":"Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118(4):692\u2013702.","journal-title":"Circ Res"},{"issue":"6917","key":"2066_CR99","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868\u201374.","journal-title":"Nature"},{"issue":"2","key":"2066_CR100","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3988\/jcn.2011.7.2.69","volume":"7","author":"SH Heo","year":"2011","unstructured":"Heo SH, Cho C-H, Kim HO, Jo YH, Yoon K-S, Lee JH, et al. Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of Matrix metalloproteinases 2 and 9. J Clin Neurol. 2011;7(2):69\u201376.","journal-title":"J Clin Neurol"},{"key":"2066_CR101","doi-asserted-by":"crossref","unstructured":"Chen LB, Buchanan JM. Mitogenic activity of blood components. I. Thrombin and prothrombin. Proceedings of the National Academy of Sciences. 1975;72(1):131-5.","DOI":"10.1073\/pnas.72.1.131"},{"issue":"22","key":"2066_CR102","doi-asserted-by":"publisher","first-page":"18915","DOI":"10.1074\/jbc.M008802200","volume":"276","author":"NR Madamanchi","year":"2001","unstructured":"Madamanchi NR, Li S, Patterson C, Runge MS. Thrombin regulates vascular smooth muscle cell growth and heat shock proteins via the JAK-STAT pathway. J Biol Chem. 2001;276(22):18915\u201324.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"2066_CR103","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11010-014-2151-y","volume":"396","author":"K Smiljanic","year":"2014","unstructured":"Smiljanic K, Obradovic M, Jovanovic A, Djordjevic J, Dobutovic B, Jevremovic D, et al. Thrombin stimulates VSMC proliferation through an EGFR-dependent pathway: involvement of MMP-2. Mol Cell Biochem. 2014;396(1\u20132):147\u201360.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"2066_CR104","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cellsig.2015.11.003","volume":"28","author":"D Kamato","year":"2016","unstructured":"Kamato D, Thach L, Getachew R, Burch M, Hollenberg MD, Zheng W, et al. Protease activated receptor-1 mediated dual kinase receptor transactivation stimulates the expression of glycosaminoglycan synthesizing genes. Cell Signal. 2016;28(1):110\u20139.","journal-title":"Cell Signal"},{"issue":"1","key":"2066_CR105","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1160\/TH11-11-0756","volume":"108","author":"SG Mahajan","year":"2012","unstructured":"Mahajan SG, Fender AC, Meyer-Kirchrath J, Kurt M, Barth M, Sagban TA, et al. A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation. Thromb Haemost. 2012;108(1):148\u201358.","journal-title":"Thromb Haemost"},{"issue":"8","key":"2066_CR106","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/biosci\/biv084","volume":"65","author":"MP Zaborowski","year":"2015","unstructured":"Zaborowski MP, Balaj L, Breakefield XO, Lai CP. Extracellular vesicles: composition, Biological relevance, and methods of study. Bioscience. 2015;65(8):783\u201397.","journal-title":"Bioscience"},{"key":"2066_CR107","doi-asserted-by":"publisher","first-page":"907457","DOI":"10.3389\/fcvm.2022.907457","volume":"9","author":"R Zhou","year":"2022","unstructured":"Zhou R, Bozbas E, Allen-Redpath K, Yaqoob P. Circulating Extracellular vesicles are strongly Associated with Cardiovascular Risk markers. Front Cardiovasc Med. 2022;9:907457.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"2066_CR108","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tmrv.2019.02.002","volume":"33","author":"A Wannez","year":"2019","unstructured":"Wannez A, Devalet B, Chatelain B, Chatelain C, Dogn\u00e9 JM, Mullier F. Extracellular vesicles in Red Blood Cell concentrates: an overview. Transfus Med Rev. 2019;33(2):125\u201330.","journal-title":"Transfus Med Rev"},{"issue":"1","key":"2066_CR109","doi-asserted-by":"publisher","first-page":"1322454","DOI":"10.1080\/20013078.2017.1322454","volume":"6","author":"T Vajen","year":"2017","unstructured":"Vajen T, Benedikter BJ, Heinzmann ACA, Vasina EM, Henskens Y, Parsons M, et al. Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype. J Extracell Vesicles. 2017;6(1):1322454.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2066_CR110","doi-asserted-by":"publisher","first-page":"1781427","DOI":"10.1080\/20013078.2020.1781427","volume":"9","author":"MJ Boyer","year":"2020","unstructured":"Boyer MJ, Kimura Y, Akiyama T, Baggett AY, Preston KJ, Scalia R, et al. Endothelial cell-derived extracellular vesicles alter vascular smooth muscle cell phenotype through high-mobility group box proteins. J Extracell Vesicles. 2020;9(1):1781427.","journal-title":"J Extracell Vesicles"},{"key":"2066_CR111","doi-asserted-by":"crossref","unstructured":"Schurgers LJ, Akbulut AC, Kaczor DM, Halder M, Koenen RR, Kramann R. Initiation and propagation of vascular calcification is regulated by a concert of platelet- and smooth muscle cell-derived extracellular vesicles. Front Cardiovasc Med. 2018;5.","DOI":"10.3389\/fcvm.2018.00036"},{"issue":"4","key":"2066_CR112","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1161\/01.CIR.0000136032.40666.3D","volume":"110","author":"V Llorente-Cort\u00e9s","year":"2004","unstructured":"Llorente-Cort\u00e9s V, Otero-Vi\u00f1as M, Camino-L\u00f3pez S, Llampayas O, Badimon L. Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells. Circulation. 2004;110(4):452\u20139.","journal-title":"Circulation"},{"issue":"2","key":"2066_CR113","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1161\/01.RES.87.2.126","volume":"87","author":"AD Schecter","year":"2000","unstructured":"Schecter AD, Spirn B, Rossikhina M, Giesen PL, Bogdanov V, Fallon JT, et al. Release of active tissue factor by human arterial smooth muscle cells. Circ Res. 2000;87(2):126\u201332.","journal-title":"Circ Res"},{"issue":"4","key":"2066_CR114","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/jth.14406","volume":"17","author":"AS Rothmeier","year":"2019","unstructured":"Rothmeier AS, Versteeg HH, Ruf W. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells. J Thromb Haemost. 2019;17(4):627\u201334.","journal-title":"J Thromb Haemost"},{"key":"2066_CR115","doi-asserted-by":"crossref","unstructured":"Sung DK, Sung SI, Ahn SY, Chang YS, Park WS. Thrombin Preconditioning boosts Biogenesis of Extracellular vesicles from mesenchymal stem cells and enriches their Cargo contents via protease-activated receptor-mediated signaling pathways. Int J Mol Sci. 2019;20(12).","DOI":"10.3390\/ijms20122899"},{"issue":"3","key":"2066_CR116","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s00018-022-04222-4","volume":"79","author":"R Suades","year":"2022","unstructured":"Suades R, Padr\u00f3 T, Vilahur G, Badimon L. Platelet-released extracellular vesicles: the effects of thrombin activation. Cell Mol Life Sci. 2022;79(3):190.","journal-title":"Cell Mol Life Sci"},{"issue":"7256","key":"2066_CR117","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nature08195","volume":"460","author":"KR Cordes","year":"2009","unstructured":"Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009;460(7256):705\u201310.","journal-title":"Nature"},{"issue":"6","key":"2066_CR118","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1159\/000445588","volume":"38","author":"M Tan","year":"2016","unstructured":"Tan M, Yan HB, Li JN, Li WK, Fu YY, Chen W, et al. Thrombin stimulated platelet-derived exosomes inhibit platelet-derived growth factor receptor-Beta expression in vascular smooth muscle cells. Cell Physiol Biochem. 2016;38(6):2348\u201365.","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"2066_CR119","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1161\/ATVBAHA.113.302161","volume":"33","author":"TE Walshe","year":"2013","unstructured":"Walshe TE, dela Paz NG, D\u2019Amore PA. The role of shear-induced transforming growth factor-\u03b2 signaling in the endothelium. Arterioscler Thromb Vasc Biol. 2013;33(11):2608\u201317.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2066_CR120","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jvs.2011.12.038","volume":"56","author":"PA Suwanabol","year":"2012","unstructured":"Suwanabol PA, Seedial SM, Shi X, Zhang F, Yamanouchi D, Roenneburg D, et al. Transforming growth factor-\u03b2 increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways. J Vasc Surg. 2012;56(2):446\u201354.","journal-title":"J Vasc Surg"},{"key":"2066_CR121","doi-asserted-by":"publisher","first-page":"43079","DOI":"10.1038\/srep43079","volume":"7","author":"CS Moran","year":"2017","unstructured":"Moran CS, Seto SW, Krishna SM, Sharma S, Jose RJ, Biros E, et al. Parenteral administration of factor Xa\/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis. Sci Rep. 2017;7:43079.","journal-title":"Sci Rep"},{"key":"2066_CR122","doi-asserted-by":"crossref","unstructured":"Ungefroren H, Witte D, Fiedler C, G\u00e4deken T, Kaufmann R, Lehnert H et al. The role of PAR2 in TGF-\u03b21-Induced ERK activation and cell motility. Int J Mol Sci. 2017;18(12).","DOI":"10.3390\/ijms18122776"},{"issue":"11","key":"2066_CR123","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1111\/ajt.17104","volume":"22","author":"D Jaishankar","year":"2022","unstructured":"Jaishankar D, Quinn KM, Sanders J, Plumblee L, Morinelli TA, Nadig SN. Connexins in endothelial cells as a therapeutic target for solid organ transplantation. Am J Transpl. 2022;22(11):2502\u20138.","journal-title":"Am J Transpl"},{"issue":"1","key":"2066_CR124","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/07853890802186921","volume":"41","author":"J-J Chiu","year":"2009","unstructured":"Chiu J-J, Usami S, Chien S. Vascular endothelial responses to altered shear stress: pathologic implications for atherosclerosis. Ann Med. 2009;41(1):19\u201328.","journal-title":"Ann Med"},{"issue":"32","key":"2066_CR125","doi-asserted-by":"publisher","first-page":"23105","DOI":"10.1074\/jbc.M113.467019","volume":"288","author":"KM Austin","year":"2013","unstructured":"Austin KM, Nguyen N, Javid G, Covic L, Kuliopulos A. Noncanonical matrix metalloprotease-1-protease-activated Receptor-1 signaling triggers vascular smooth muscle cell dedifferentiation and arterial Stenosis*. J Biol Chem. 2013;288(32):23105\u201315.","journal-title":"J Biol Chem"},{"issue":"2","key":"2066_CR126","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.beha.2013.07.009","volume":"26","author":"R Shameem","year":"2013","unstructured":"Shameem R, Ansell J. Disadvantages of VKA and requirements for novel anticoagulants. Best Pract Res Clin Haematol. 2013;26(2):103\u201314.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1","key":"2066_CR127","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/bcpt.12834","volume":"122","author":"A Siltari","year":"2018","unstructured":"Siltari A, Vapaatalo H. Vascular calcification, Vitamin K and warfarin therapy \u2013 possible or plausible connection? Basic Clin Pharmacol Toxicol. 2018;122(1):19\u201324.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2066_CR128","doi-asserted-by":"crossref","unstructured":"Repges E, Al Zaidi MAZ, Jansen FJ, Zimmer SZ, Tiyerlili VT, Nickenig GN et al. The vitamin-k-cycle-enzyme VKORC1L1, but not its isoenzyme VKORC1, reduces inflammation in coronary endothelial cells. Eur Heart J. 2023;44(Supplement_2).","DOI":"10.1093\/eurheartj\/ehad655.3226"},{"issue":"6","key":"2066_CR129","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.amjcard.2005.05.014","volume":"96","author":"R Koos","year":"2005","unstructured":"Koos R, Mahnken AH, M\u00fchlenbruch G, Brandenburg V, Pflueger B, Wildberger JE, et al. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am J Cardiol. 2005;96(6):747\u20139.","journal-title":"Am J Cardiol"},{"issue":"8","key":"2066_CR130","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1161\/01.ATV.0000173313.46222.43","volume":"25","author":"LJ Schurgers","year":"2005","unstructured":"Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, Appels A, et al. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol. 2005;25(8):1629\u201333.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2066_CR131","doi-asserted-by":"publisher","first-page":"oeab017","DOI":"10.1093\/ehjopen\/oeab017","volume":"1","author":"RH van Gorp","year":"2021","unstructured":"van Gorp RH, Baaten C, Habibi A, Jaminon AMG, Peeters F, Leenders P, et al. Vitamin K antagonist use induces calcification and atherosclerotic plaque progression resulting in increased hypercoagulability. Eur Heart J Open. 2021;1(2):oeab017.","journal-title":"Eur Heart J Open"},{"issue":"4","key":"2066_CR132","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.1055\/s-0038-1675578","volume":"2","author":"F Peeters","year":"2018","unstructured":"Peeters F, Dudink E, Kimenai DM, Weijs B, Altintas S, Heckman LIB, et al. Vitamin K Antagonists, non-vitamin K antagonist oral anticoagulants, and vascular calcification in patients with Atrial Fibrillation. TH Open. 2018;2(4):e391\u20138.","journal-title":"TH Open"},{"issue":"17","key":"2066_CR133","doi-asserted-by":"publisher","first-page":"e008650","DOI":"10.1161\/JAHA.118.008650","volume":"7","author":"L Eggebrecht","year":"2018","unstructured":"Eggebrecht L, Prochaska JH, Schulz A, Arnold N, J\u00fcnger C, G\u00f6bel S, et al. Intake of Vitamin K Antagonists and worsening of Cardiac and Vascular Disease: results from the Population-based Gutenberg Health Study. J Am Heart Assoc. 2018;7(17):e008650.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"2066_CR134","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/ATVBAHA.120.315506","volume":"41","author":"M Furmanik","year":"2021","unstructured":"Furmanik M, van Gorp R, Whitehead M, Ahmad S, Bordoloi J, Kapustin A, et al. Endoplasmic reticulum stress mediates vascular smooth muscle cell calcification via increased release of Grp78 (glucose-Regulated protein, 78\u00a0kDa)-Loaded Extracellular vesicles. Arterioscler Thromb Vasc Biol. 2021;41(2):898\u2013914.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"2066_CR135","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1182\/blood-2004-10-3985","volume":"105","author":"C Feistritzer","year":"2005","unstructured":"Feistritzer C, Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood. 2005;105(8):3178\u201384.","journal-title":"Blood"},{"issue":"3","key":"2066_CR136","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mpmed.2020.12.003","volume":"49","author":"S Boyce","year":"2021","unstructured":"Boyce S, James I. Direct oral anticoagulants and the management of bleeding. Medicine. 2021;49(3):131\u20135.","journal-title":"Medicine"},{"issue":"10","key":"2066_CR137","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1161\/CIRCULATIONAHA.105.574830","volume":"114","author":"AJ Leger","year":"2006","unstructured":"Leger AJ, Covic L, Kuliopulos A. Protease-activated receptors in Cardiovascular diseases. Circulation. 2006;114(10):1070\u20137.","journal-title":"Circulation"},{"key":"2066_CR138","doi-asserted-by":"publisher","first-page":"432080","DOI":"10.1155\/2011\/432080","volume":"2011","author":"Q Zhou","year":"2011","unstructured":"Zhou Q, Bea F, Preusch M, Wang H, Isermann B, Shahzad K, et al. Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor xa inhibitor rivaroxaban. Mediators Inflamm. 2011;2011:432080.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"2066_CR139","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1038\/s41598-019-40602-w","volume":"9","author":"JJ Posthuma","year":"2019","unstructured":"Posthuma JJ, Posma JJN, van Oerle R, Leenders P, van Gorp RH, Jaminon AMG, et al. Targeting coagulation factor Xa promotes regression of Advanced atherosclerosis in Apolipoprotein-E deficient mice. Sci Rep. 2019;9(1):3909.","journal-title":"Sci Rep"},{"key":"2066_CR140","doi-asserted-by":"publisher","first-page":"739212","DOI":"10.3389\/fcvm.2021.739212","volume":"8","author":"Y Ma","year":"2021","unstructured":"Ma Y, Zhang Y, Qiu C, He C, He T, Shi S, et al. Rivaroxaban suppresses atherosclerosis by inhibiting FXa-Induced Macrophage M1 polarization-mediated phenotypic Conversion of Vascular smooth muscle cells. Front Cardiovasc Med. 2021;8:739212.","journal-title":"Front Cardiovasc Med"},{"issue":"16","key":"2066_CR141","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.2146\/ajhp100348","volume":"68","author":"ML Blommel","year":"2011","unstructured":"Blommel ML, Blommel AL. Dabigatran etexilate: a novel oral direct thrombin inhibitor. Am J Health Syst Pharm. 2011;68(16):1506\u201319.","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"2066_CR142","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3390\/ijms21061953","volume":"21","author":"E Wo\u017aniak","year":"2020","unstructured":"Wo\u017aniak E, Broncel M, Bukowska B, Gorzelak-Pabi\u015b P. The Protective Effect of Dabigatran and Rivaroxaban on DNA oxidative changes in a model of vascular endothelial damage with oxidized cholesterol. Int J Mol Sci. 2020;21(6):1953.","journal-title":"Int J Mol Sci"},{"key":"2066_CR143","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10557-012-6411-3","volume":"26","author":"NPE Kadoglou","year":"2012","unstructured":"Kadoglou NPE, Moustardas P, Katsimpoulas M, Kapelouzou A, Kostomitsopoulos NG, Schafer K, et al. The Beneficial effects of a direct thrombin inhibitor, Dabigatran Etexilate, on the Development and Stability of Atherosclerotic Lesions in apolipoprotein E-deficient mice. Cardiovasc Drugs Ther. 2012;26:367\u201374.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"7","key":"2066_CR144","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/hq0701.093686","volume":"21","author":"J Hirsh","year":"2001","unstructured":"Hirsh J, Anand SS, Halperin JL, Fuster V. Mechanism of Action and Pharmacology of Unfractionated Heparin. Arterioscler Thromb Vasc Biol. 2001;21(7):1094\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2066_CR145","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2217\/fca-2019-0090","volume":"16","author":"US Tantry","year":"2020","unstructured":"Tantry US, Bliden KP, Chaudhary R, Novakovic M, Rout A, Gurbel PA. Vorapaxar in the treatment of cardiovascular diseases. Future Cardiol. 2020;16(5):373\u201384.","journal-title":"Future Cardiol"},{"issue":"2","key":"2066_CR146","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/ATVBAHA.117.310550","volume":"38","author":"X Han","year":"2018","unstructured":"Han X, Nieman MT. PAR4 (protease-Activated receptor 4): PARticularly important 4 antiplatelet therapy. Arterioscler Thromb Vasc Biol. 2018;38(2):287\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"2066_CR147","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1111\/jth.13293","volume":"14","author":"SL French","year":"2016","unstructured":"French SL, Arthur JF, Lee H, Nesbitt WS, Andrews RK, Gardiner EE, et al. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood. J Thromb Haemost. 2016;14(8):1642\u201354.","journal-title":"J Thromb Haemost"},{"issue":"23","key":"2066_CR148","doi-asserted-by":"publisher","first-page":"464","DOI":"10.21037\/atm.2017.09.10","volume":"5","author":"SL French","year":"2017","unstructured":"French SL, Hamilton JR. Drugs targeting protease-activated receptor-4 improve the antithrombotic therapeutic window. Annals Translational Med. 2017;5(23):464.","journal-title":"Annals Translational Med"},{"issue":"1","key":"2066_CR149","doi-asserted-by":"publisher","first-page":"2222846","DOI":"10.1080\/09537104.2023.2222846","volume":"34","author":"S Merali","year":"2023","unstructured":"Merali S, Wang Z, Frost C, Meadows-Shropshire S, Hawthorne D, Yang J, et al. First-in-human study to assess the safety, pharmacokinetics, and pharmacodynamics of BMS-986141, a novel, reversible, small-molecule, PAR4 agonist in non-japanese and Japanese healthy participants. Platelets. 2023;34(1):2222846.","journal-title":"Platelets"},{"key":"2066_CR150","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-1-4939-2806-4_13","volume":"1324","author":"P Zhang","year":"2015","unstructured":"Zhang P, Covic L, Kuliopulos A. Pepducins and other lipidated peptides as mechanistic probes and therapeutics. Methods Mol Biol. 2015;1324:191\u2013203.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"2066_CR151","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1161\/ATVBAHA.120.315168","volume":"40","author":"A Kuliopulos","year":"2020","unstructured":"Kuliopulos A, Gurbel PA, Rade JJ, Kimmelstiel CD, Turner SE, Bliden KP, et al. PAR1 (protease-Activated receptor 1) pepducin therapy targeting myocardial necrosis in coronary artery Disease and Acute Coronary Syndrome patients undergoing Cardiac catheterization: a randomized, Placebo-Controlled, phase 2 study. Arterioscler Thromb Vasc Biol. 2020;40(12):2990\u20133003.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"2066_CR152","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1161\/ATVBAHA.111.238261","volume":"31","author":"LM Sevigny","year":"2011","unstructured":"Sevigny LM, Austin KM, Zhang P, Kasuda S, Koukos G, Sharifi S, et al. Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia. Arterioscler Thromb Vasc Biol. 2011;31(12):e100\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl1","key":"2066_CR153","first-page":"A449","volume":"39","author":"HM Russell","year":"2019","unstructured":"Russell HM, Conrad KA, Benoit JA, Wanhainen A, Mix DS, Cameron SJ, et al. Abstract 449: Pepducin inhibition of protease-activated receptor 2 attenuates a mouse model of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 2019;39(Suppl1):A449\u2013A.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2066_CR154","first-page":"587A","volume":"60","author":"AM Shearer","year":"2014","unstructured":"Shearer AM, Austin K, Guha S, Nguyen N, Looby R, Clappin A, et al. Protease-activated Receptor-2 (PAR2)-A Novel Therapeutic Target in Nonalcoholic Steatohepatitis (NASH): 803. Hepatology. 2014;60:587A.","journal-title":"Hepatology"},{"issue":"3","key":"2066_CR155","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.pharmthera.2009.05.004","volume":"123","author":"N Vergnolle","year":"2009","unstructured":"Vergnolle N. Protease-activated receptors as drug targets in inflammation and pain. Pharmacol Ther. 2009;123(3):292\u2013309.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"2066_CR156","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1124\/pr.54.2.203","volume":"54","author":"MD Hollenberg","year":"2002","unstructured":"Hollenberg MD, Compton SJ. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev. 2002;54(2):203\u201317.","journal-title":"Pharmacol Rev"},{"issue":"6801","key":"2066_CR157","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/35025229","volume":"407","author":"SR Coughlin","year":"2000","unstructured":"Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407(6801):258\u201364.","journal-title":"Nature"},{"issue":"1","key":"2066_CR158","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/ijms26010410","volume":"26","author":"L Khoon","year":"2025","unstructured":"Khoon L, Piran R. A New Strategy in modulating the protease-activated receptor 2 (Par2) in Autoimmune diseases. Int J Mol Sci. 2025;26(1):410.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2066_CR159","doi-asserted-by":"publisher","first-page":"1968763","DOI":"10.1080\/21688370.2021.1968763","volume":"10","author":"M Bandara","year":"2022","unstructured":"Bandara M, MacNaughton WK. Protease-activated receptor-2 activation enhances epithelial wound healing via epidermal growth factor receptor. Tissue Barriers. 2022;10(2):1968763.","journal-title":"Tissue Barriers"},{"issue":"1","key":"2066_CR160","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1021\/acsmedchemlett.8b00538","volume":"10","author":"MW Majewski","year":"2019","unstructured":"Majewski MW, Gandhi DM, Rosas R Jr., Kodali R, Arnold LA, Dockendorff C. Design and evaluation of Heterobivalent PAR1\u2013PAR2 ligands as antagonists of Calcium mobilization. ACS Med Chem Lett. 2019;10(1):121\u20136.","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"2066_CR161","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s11658-022-00382-0","volume":"27","author":"I Lee-Rivera","year":"2022","unstructured":"Lee-Rivera I, L\u00f3pez E, L\u00f3pez-Colom\u00e9 AM. Diversification of PAR signaling through receptor crosstalk. Cell Mol Biol Lett. 2022;27(1):77.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"2066_CR162","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12959-019-0194-8","volume":"17","author":"DM Heuberger","year":"2019","unstructured":"Heuberger DM, Schuepbach RA. Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases. Thromb J. 2019;17(1):4.","journal-title":"Thromb J"},{"issue":"9","key":"2066_CR163","doi-asserted-by":"publisher","first-page":"8298","DOI":"10.3390\/ijms24098298","volume":"24","author":"SA Renna","year":"2023","unstructured":"Renna SA, McKenzie SE, Michael JV. Species differences in platelet protease-activated receptors. Int J Mol Sci. 2023;24(9):8298.","journal-title":"Int J Mol Sci"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02066-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T12:05:34Z","timestamp":1738325134000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02066-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":163,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2066"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02066-6","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}